Lv12
10 积分 2025-08-03 加入
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
1小时前
已完结
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
3小时前
已完结
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis
1天前
已完结
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
11天前
已完结
Cardiotoxicities of novel cancer immunotherapies
11天前
已完结
Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19
11天前
已完结
Cardiovascular toxicity of immune therapies for cancer
12天前
已完结
Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy
12天前
已完结
MLKL–Mediated Necroptosis Predominantly Contributes to Immune-Associated Myocardial Damage
12天前
已完结
Mediation of macrophage M1 polarization dynamics change by ubiquitin-autophagy-pathway regulated NLRP3 inflammasomes in PD-1 inhibitor-related myocardial inflammatory injury
18天前
已完结
皖公网安备34019202002308
